Invention Grant
- Patent Title: Nasal vaccine for Streptococcus pneumoniae
-
Application No.: US15119335Application Date: 2015-02-16
-
Publication No.: US09833407B2Publication Date: 2017-12-05
- Inventor: Yoshikazu Yuki , Hiroshi Kiyono , Kazunari Akiyoshi , Shinichi Sawada
- Applicant: LSIP, LLC
- Applicant Address: JP Tokyo
- Assignee: Intellectual Property Strategy Network, Inc.
- Current Assignee: Intellectual Property Strategy Network, Inc.
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2014-027205 20140217
- International Application: PCT/JP2015/054146 WO 20150216
- International Announcement: WO2015/122518 WO 20150820
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K39/02 ; A61K39/00 ; A61K9/00 ; A61K9/06 ; A61K47/36
Abstract:
The present invention provides a nasal vaccine for Streptococcus pneumoniae, and a production method therefor. This nasal vaccine formulation for primates includes a complex of PspA, i.e. the vaccine antigen, and a nanogel in which hydrophobic cholesterol is added, as side chains, to pullulan having amino groups. Furthermore, the present invention provides a production method for the nasal vaccine formulation for primates.
Public/Granted literature
- US20170014338A1 NASAL VACCINE FOR STREPTOCOCCUS PNEUMONIAE Public/Granted day:2017-01-19
Information query
